Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 113,692 |
|
|||||
| News | - | ||||||
| Day High | 1.01 | Low High |
|||||
| Day Low | 0.99 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kronos Bio Inc | KRON | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0095 | -0.95% | 0.99 | 14:00:46 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.01 | 0.99 | 1.01 | 0.9995 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 366 | 113,692 | $ 1.00 | $ 113,790 | - | 0.731 - 2.29 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:06:28 | 3 | $ 0.991 | USD |
Kronos Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 57.73M | 58.32M | - | 6.29M | -112.67M | -1.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kronos Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KRON Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.03 | 1.09 | 0.9614 | 1.02 | 401,257 | -0.04 | -3.88% |
| 1 Month | 1.08 | 1.12 | 0.90 | 0.9907325 | 602,159 | -0.09 | -8.33% |
| 3 Months | 1.06 | 1.40 | 0.90 | 1.08 | 444,689 | -0.07 | -6.60% |
| 6 Months | 0.7512 | 1.5053 | 0.7512 | 1.10 | 317,230 | 0.2388 | 31.79% |
| 1 Year | 1.73 | 2.29 | 0.731 | 1.27 | 284,896 | -0.74 | -42.77% |
| 3 Years | 24.68 | 28.42 | 0.731 | 6.24 | 298,364 | -23.69 | -95.99% |
| 5 Years | 28.29 | 39.605 | 0.731 | 9.30 | 285,514 | -27.30 | -96.50% |
Kronos Bio Description
| Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. |
